Publicaciones (25) Publicaciones de José Manuel Muñoz Félix

2024

  1. The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

2023

  1. Author Correction: Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth (Nature Communications, (2020), 11, 1, (2810), 10.1038/s41467-020-16618-6)

    Nature Communications

2022

  1. Endothelial Activin Receptor-Like Kinase 1 (ALK1) Regulates Myofibroblast Emergence and Peritubular Capillary Stability in the Early Stages of Kidney Fibrosis

    Frontiers in Pharmacology, Vol. 13

2021

  1. Dissecting the Involvement of Ras GTPases in Kidney Fibrosis

    Genes, Vol. 12, Núm. 6

  2. Improved immunotherapy efficacy by vascular modulation

    Cancers, Vol. 13, Núm. 20

  3. The dual effect of the BMP9–ALK1 pathway in blood vessels: An opportunity for cancer therapy improvement?

    Cancers, Vol. 13, Núm. 21

2020

  1. Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor Cells

    Cell, Vol. 181, Núm. 6, pp. 1346-1363.e21

  2. Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth

    Nature Communications, Vol. 11, Núm. 1

  3. “Splitting the matrix”: intussusceptive angiogenesis meets MT1-MMP

    EMBO Molecular Medicine

2019

  1. Cardiotrophin-1 opposes renal fibrosis in mice: Potential prevention of chronic kidney disease

    Acta Physiologica, Vol. 226, Núm. 2

  2. Novel Pure αvβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations

    ACS Pharmacology and Translational Science, Vol. 2, Núm. 6, pp. 387-401

2018

  1. Impaired erythropoietin synthesis in chronic kidney disease is caused by alterations in extracellular matrix composition

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 1, pp. 302-314

2017

  1. Dual role of pericyte α6β1-integrin in tumour blood vessels

    Journal of Cell Science, Vol. 130, Núm. 9, pp. 1583-1595

  2. Overcoming the Lack of Oral Availability of Cyclic Hexapeptides: Design of a Selective and Orally Available Ligand for the Integrin αvβ3

    Angewandte Chemie - International Edition, Vol. 56, Núm. 51, pp. 16405-16409

2016

  1. Absence of K-Ras Reduces Proliferation and Migration But Increases Extracellular Matrix Synthesis in Fibroblasts

    Journal of Cellular Physiology, Vol. 231, Núm. 10, pp. 2224-2235

  2. Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro

    Cellular Signalling, Vol. 28, Núm. 9, pp. 1252-1261

  3. Overexpression of the short endoglin isoform reduces renal fibrosis and inflammation after unilateral ureteral obstruction

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1862, Núm. 9, pp. 1801-1814

2015

  1. TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?

    Pharmacology and Therapeutics, Vol. 156, pp. 44-58

2014

  1. ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1843, Núm. 6, pp. 1111-1122

  2. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy

    Kidney International, Vol. 85, Núm. 2, pp. 319-332